Vimal Mehta

Founder at BIOXCEL THERAPEUTICS, INC.

Net worth: 81 832 $ as of 30/05/2026

65 year

37 connections

Health Technology

Consumer Services

Distribution Services

Profile

Vimal D.
Mehta is the founder of BioXcel Corp., founded in 2005, serving as Chairman & Chief Executive Officer since 2014.
Dr. Mehta is the founder of BioXcel Therapeutics, Inc., founded in 2017, serving as President, Chief Executive Officer & Director since 2021.
Former jobs include Director at Invea Therapeutics, Inc., Manager-Business Development at CuraGen Corp.
from 1996 to 2002, Senior Vice President-Business Development at Alfasigma UK Ltd. from 2002 to 2006, Assistant Professor at The University of Texas Southwestern Medical Center from 1989 to 1996, and Senior Vice President-Business Development at Jubilant Life Sciences (USA), Inc. from 2006 to 2007.
Education includes a doctorate from the University of Delhi.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BIOXCEL THERAPEUTICS, INC. 0.48%	14/06/2026	69,942 ( 0.48% )	81 832 $	30/05/2026

Vimal Mehta active positions

Companies	Position	Start
BIOXCEL THERAPEUTICS, INC.	Founder	28/03/2017
BioXcel Corp. BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions	Chief Executive Officer	31/12/2004

All active positions of Vimal Mehta

Former positions of Vimal Mehta

Companies	Position	End
Invea Therapeutics, Inc. Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs	Director/Board Member	31/12/2022
Jubilant Life Sciences (USA), Inc. Jubilant Life Sciences (USA), Inc. Medical DistributorsDistribution Services Wholesales pharmaceuticals	Corporate Officer/Principal	31/12/2006
Galapagos Biotech Ltd. Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services	Corporate Officer/Principal	31/12/2005
CuraGen Corp. CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products	Corporate Officer/Principal	31/12/2001
The University of Texas Southwestern Medical Center The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	31/12/1995

See the detail of Vimal Mehta's experience

Training of Vimal Mehta

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Vimal Mehta's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
CuraGen Corp. CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products	Health Technology
Galapagos Biotech Ltd. Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services	Health Technology
University of Delhi University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of Texas Southwestern Medical Center The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Jubilant Life Sciences (USA), Inc. Jubilant Life Sciences (USA), Inc. Medical DistributorsDistribution Services Wholesales pharmaceuticals	Distribution Services
BioXcel Corp. BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions	Technology Services
BioXcel Therapeutics, Inc. BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology	Health Technology
Invea Therapeutics, Inc. Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs	Health Technology